Obsidian Therapeutics (OBX) stock

Cell therapies , market cap $861M

Cell therapies for solid tumors

Market cap $861M

$13.86

-0.86%

As of Monday's close · Live for Pro members at the open

Quality Score

Below Average

In its industry

#117of 291

Biotech

Checks firing

4of 14

Transition

From its high

-72.3%

No 200-day yet

OBX's Quality Score rose 1 point on Mon, Oct 26, to 1. Closed above its rising 21-day average (2 chart checks started).

New listing, trading since Aug 4, 2026. 59 trading days so far, so 4 of the 14 chart checks wait for more history.

Follow OBX's trial news. Pro members can get an alert when Obsidian Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when OBX files news on its trialSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Next1H 2027“We expect additional NSCLC Phase 1 clinical data will be available in the first half of 2027…”Trial data · SEC filing · Aug 3

Key facts on OBX

Key facts on OBX
Holding it back	Moves 11.7% a day with no profit behind it
Latest filing	S-1, Aug 28 Registered shares for sale (S-1)

1 more reason behind OBX's 1, for Pro members.

OBX catalysts

Coming up

1 past catalyst since 2026, with sizes and sources, for Pro members.Get in free →

What's next for OBX, and how long its cash lasts

Next step the company has named

1H 2027“We expect additional NSCLC Phase 1 clinical data will be available in the first half of 2027 and expect to announce melanoma registration-enabling data by the end of 2027.”Trial data · SEC filing · Aug 3

What it means: the first look at a trial’s main results, as the company reports them.

A trial underway: Agni-01Phase 1/2 · Recruiting · 254 people · main data estimated Jun 30, 2029 · NCT06060613

For Pro members: 1 more milestone and 2 filings.

Cash runway Jun 30 balance sheet

$0 in cash

Fewer than four quarters of cash flow are on file.

What it means: a runway is counted only when each of the last four quarters used cash. The company's estimate is “into 2H 2028” (8-K, Aug 3). It has raised money since that balance sheet, which is not counted here.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

No shelf registration or at-the-market program on file in the last three years.

For Pro members: 1 raise and its amount, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

Get an alert when Madan Jagasia buys or sells

For Pro members: every trade, and Madan Jagasia’s 3 filings and quotes.

Get an alert when OBX files news on its trialSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 14 daysANDA decisionIn 14 days · ANDA decisionNRXPNRX PharmaceuticalsPreservative-free ketamineNRXPNRX Pharmaceuticals · $104MPreservative-free ketamineA generic, under FDA review (GDUFA)
In 26 daysFDA decisionIn 26 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $356MDeramiocelFDA decision due (PDUFA)
In 26 daysFDA decisionIn 26 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $933MMolgramostimFDA decision due (PDUFA)

10 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 169 dates, ranked →

Why OBX scores 1

Below AverageTransition, 4 of 14 chart checks firingWhat the Quality Score means

+4Chart checks 4 of 14 firing right now, one point each
−2Volatility moves 11.7% a day with no profit or positive free cash flow over four quarters on fileA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.

Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.

No effect today: Long-term trend, Run-up, Size, Growth, Dilution, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on OBX and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 12:12 AM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when OBX's Quality Score turns up

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

The same page for Pro members, on AMD
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on OBX and every other stock.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

OBX has 4 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on OBX, and all 14 on every stock.Get in free →

OBX RSI on Oct 26: 41.1, below its 50-day average

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

RSI 1441.1
Above 30, below 50.
MACD (12, 26, 9)Above signal
Crossed above its signal line 18 sessions ago.
50-day average$15.68
The price is 11.6% below it.
200-day average
Not enough history yet.
50/200 cross
Not enough history yet.
ADX 1420.9
Under 25, with +DI below -DI.
Support$12.16
Swing low from Sep 25, 12.3% below the price.
Resistance$19.96
Swing high from Sep 9, 44.0% above the price.
High since listing$49.97
From Aug 4, 260.5% above the price.
Low since listing$11.52
From Oct 19, 16.9% below the price.
Chart patternWedge
Lines over the Sep 21 and Oct 21 highs and under the Sep 25 and Oct 19 lows.
Bollinger Bands (20, 2)Inside
The bands run from $11.52 to $14.74.
Volume0.6x
Against its 20-day average, for the time of day.

The deep dive on OBX

What it does and how it makes money1 findingFor Pro members1 finding on what OBX does and how it makes money, for Pro members
Where it stands1 finding$0 in cash and short-term investments on Jun 30, 2026.Balance sheet of Jun 30, 2026, filed Aug 14, 2026
Who holds and trades it2 findingsFor Pro members2 findings on who holds and trades OBX, for Pro members

3 more findings on OBX, each with its source, for Pro membersGet in free →

How OBX ranks in Biotech

OBX is #117 of 291 by Quality Score.

How OBX ranks in Biotech
1	HALOHalozyme Therapeutics	9/14	21
2	AMRXAmneal Pharmaceuticals	9/14	20
3	RIGLRigel Pharmaceuticals	9/14	19
	NVAXNovavax		Open for its score
	OABIOmniAb		Open for its score
	OCULOcular Therapeutix		Open for its score
	OKUROnKure Therapeutics		Open for its score
117	OBXObsidian Therapeutics	4/14	1

OBX share count over time

Shares of OBX outstanding, as filed
Shares outstanding	As of
61.8M	Aug 10, 2026

Offerings, shelves, and splits of OBX, from its filings
From its filings	Filed
Registered shares for sale (S-1)	Aug 28, 2026
Priced a sale of shares	Jul 2, 2026

About Obsidian Therapeutics

Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.

Cambridge, MAobsidiantx.com

OBX's score card

Obsidian Therapeutics (OBX): Quality Score 1, Below Average, #117 of 291 in Biotech, with its price, on Breakaway — The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

What would turn OBX's score around: 4 things
2 more filings explained, a plain line each
Real-⁠time prices, no delay

See OBX's 14 chart checks

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Oct 27, 2026: OBX's Quality Score is 1 (Below Average), #117 of 291 in Biotech.

Is OBX a good stock to buy? What its Quality Score says

OBX scores 1 today, which Breakaway calls Below Average. It is #117 of 291 in Biotech by Quality Score, with 4 of 14 chart checks firing. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is OBX's Quality Score?

OBX scores 1 today, which Breakaway calls Below Average (0 to 5). That is #117 of 291 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind OBX's 1.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.